FREE Account Opening + No Clearing Fees
Loading...

Aarti Drugs Buyback 2023 vs CL Educate Buyback 2023

Comparision between Aarti Drugs Buyback 2023 and CL Educate Buyback 2023.

Buyback Details

Aarti Drugs Buyback 2023 is a Tender Offer buyback proposed to list at BSE, NSE while CL Educate Buyback 2023 is a Open Market Through Stock Exchange proposed to list at BSE, NSE.

  Aarti Drugs Limited CL Educate Limited
Logo Aarti Drugs Buyback 2023 Logo CL Educate Buyback 2023 Logo
Type of Buyback Tender Offer Open Market Through Stock Exchange
Listing At BSE, NSE BSE, NSE
Face Value ₹10 per share ₹5 per share
Buyback Price ₹900 per share ₹94 per share
Issue Size 6,65,000 shares
Issue Size (Amount) ₹59.85 Crores ₹15.00 Crores
Buyback Ratio
CategoryEntitlement Ratio of BuybackShares Offered
Reserved Category for Small Shareholders2 Equity Shares out of every 157 Fully paid-up Equity Shares held on the Record Date.99,750.00
General Category for all other Eligible Shareholders1 Equity Shares out of every 150 Fully paid-up Equity Shares held on the Record Date.565,250.00
Registrar Link Intime India Private Ltd Kfin Technologies Limited
Lead Managers Inga Ventures Pvt Ltd V B Desai Financial Services Limited
Necessity of the buyback

The Buy Back is being proposed by the Company to fulfill the following objectives:

  1. The Buyback will help the company to return surplus cash to its shareholders holding Equity Shares.
  2. The Buyback is generally expected to improve return on equity through the distribution of cash and improve earnings per share by a reduction in the equity base, thereby leading to a long-term increase in shareholders value.
  3. The Buyback gives an option to the shareholders holding Equity Shares of the company, either to sell their Equity Shares and receive cash or not to sell their Equity Shares and get a resultant increase in their percentage shareholding, post the Buyback offer, without additional investment.
  4. The Buyback, which is being implemented through the tender offer as prescribed under the Buyback Regulations, would involve a minimum reservation of 15% for Small Shareholders and allocation of a higher number of shares as per their entitlement or 15% of the number of shares to be bought back, reserved for the Small Shareholders. The Company believes that this reservation for Small Shareholders would benefit a large number of public shareholders, who would get classified as Small Shareholders.

The Buyback is being undertaken for the following reasons

(i) The Buyback will help the Company to return surplus cash to its shareholders holding Equity Shares;

(ii) The Buyback may help in improving return on equity, by reduction in the equity base, thereby leading to an increase in shareholders' value; and

(iii) The Buyback gives an option to the shareholders holding Equity Shares of the Company, who can choose to participate and get cash in lieu of Equity Shares to be accepted under the Buyback offer or they may choose not to participate and enjoy a resultant increase in their percentage shareholding, post the Buyback offer, without additional investment.

Buyback Timetable

Aarti Drugs Buyback 2023 and CL Educate Buyback 2023 buyback timetable. The investors should have the company's shares in their demat accounts as of the record date. Aarti Drugs Buyback 2023 Buyback record date is Aug 04, 2023. CL Educate Buyback 2023 Buyback record date is .

  Aarti Drugs Limited CL Educate Limited
Record Date Aug 04, 2023
Offer Open Date Aug 09, 2023 Aug 21, 2023
Offer Closure Date Aug 17, 2023 Nov 28, 2023
Last date for receipt of tender forms Aug 17, 2023
Finalisation of buyback Aug 23, 2023
Last Date for settlment of bids Aug 24, 2023
Last Date for extinguishment of shares Sep 04, 2023

Financial Details and Other Relevent Information

Comparison of Aarti Drugs Buyback 2023 and CL Educate Buyback 2023 financial data. The table below also includes a list of all relevant information like Stock Market Data, Compay Information, Lead Manager and Registrar.

  Aarti Drugs Limited CL Educate Limited
Financial
Aarti Drugs Buyback 2023 Financial Information (Restated Consolidated)
Period Ended31 Mar 201931 Mar 202031 Mar 202131 Mar 202231 Mar 2023
Assets1,455.491,576.501,766.012,207.962,421.40
Revenue1,436.091,626.752,159.312,499.962,718.25
Profit After Tax89.75141.40280.40205.00166.36
Net Worth904.271,026.521,184.10
Reserves and Surplus
Total Borrowing
Amount in ₹ Crore

CL Educate Limited Financial Information (Restated Consolidated)

CL Educate Limited's revenue increased by 37.73% and profit after tax (PAT) rose by 63.4% between the financial year ending with March 31, 2023 and March 31, 2022.

Period Ended31 Mar 202331 Mar 202231 Mar 202131 Mar 202031 Mar 2019
Assets372.83347.78351.67421.46493.93
Revenue297.71216.16191.91323.92352.50
Profit After Tax22.5313.79-12.60-53.0619.98
Net Worth
Reserves and Surplus247.24247.48232.82291.68346.98
Total Borrowing
Amount in ₹ Crore
Stock price at BSE

Stock price at BSE (in preceding 3 months)

Month High Price Low Price Average Price
Jun-2023 492.95 437.35 460.04
May-2023 478.25 423.00 452.48
Apr-2023 436.00 336.05 407.57

Stock price at BSE (in preceding 3 months)

Month High Price Low Price Average Price
Jul-2023 77.90 64.10 71.72
Jun-2023 71.70 60.70 66.68
May-2023 72.09 51.91 60.63
Stock price at NSE

Stock price at NSE (in preceding 3 months)

Month High Price Low Price Average Price
Jun-2023 493.00 439.10 459.93
May-2023 478.00 422.85 452.23
Apr-2023 436.00 336.00 407.91

Stock price at NSE (in preceding 3 months)

Month High Price Low Price Average Price
Jul-2023 79.00 64.05 72.14
Jun-2023 71.80 61.15 67.85
May-2023 72.20 51.75 60.02

Comments

Add a public comment...